Evidence map›Paper›PMID 42038033›Full record

ArticleJournal of Cancer2026

The Overexpression of Myelin and Lymphocyte Protein (MAL) Downregulates MUC1 and Enhances Cisplatin Sensitivity in Non-Small Cell Lung Cancer Cells.

Ana Karina Saldaña-Villa, Bismarck Vázquez-Almazán, Catalina Flores-Maldonado, Juan Carlos Vizuet-de-Rueda, Elisa Natalia Oropeza-Durán, José Bonilla-Delgado, Enoc Mariano Cortés-Malagón, Rubén Gerardo Contreras, Luis Manuel Teran, Blanca Ortiz-Quintero and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ana Karina Saldaña-VillaDepartamento de Biomedicina Molecular e Investigación Traslacional, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, MEXICO.
Bismarck Vázquez-AlmazánDepartamento de Biomedicina Molecular e Investigación Traslacional, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, MEXICO.
Catalina Flores-MaldonadoDepartamento de Fisiología, Biofísica y Neurociencias Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav). Mexico City, MEXICO.
Juan Carlos Vizuet-de-RuedaDepartmento de Inmunogénetica y Alergia, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas Mexico City, 14080, MEXICO.
Elisa Natalia Oropeza-DuránDepartamento de Biotecnología, Facultad de Ciencias de la Salud, Universidad Anáhuac México Campus Norte, Huixquilucan 52786, MEXICO.
José Bonilla-DelgadoLaboratorio de la Unidad de Investigación en Oncología Molecular, Hospital de Alta Especialidad de Ixtapaluca, Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar, Ixtapaluca 56530, MEXICO.
Enoc Mariano Cortés-MalagónDivisión de Investigación, Hospital Juárez de México 07760, Mexico City, MEXICO.
Rubén Gerardo ContrerasDepartamento de Fisiología, Biofísica y Neurociencias Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav). Mexico City, MEXICO.
Luis Manuel TeranDepartmento de Inmunogénetica y Alergia, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas Mexico City, 14080, MEXICO.
Blanca Ortiz-QuinteroDepartamento de Biomedicina Molecular e Investigación Traslacional, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, MEXICO.
Roberto Lara-LemusDepartamento de Biomedicina Molecular e Investigación Traslacional, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, MEXICO.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The epigenetic repression of myelin and lymphocyte protein gene (

Indexed as

cisplatin resistancelung cancerMUC1Myelin and lymphocyte protein

Identifiers

PMID42038033
PMCPMC13104723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.